Skip to content

Danaher DHR Cash & Equivalents

Cash & Equivalents at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.02B+49.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$509M-2.7%
GLW
CorningGLW
$2.5B+67.9%
Donaldson Company logo
Donaldson CompanyDCI
$204.1M+14.3%
Dover logo
DoverDOV
$1.76B+38.8%
Revvity logo
RevvityRVTY
$861.47M-24.3%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's cash & equivalents?
Danaher (DHR) reported cash & equivalents of $4.35B in Q2 2026.
How has Danaher's cash & equivalents changed year-over-year?
Danaher's cash & equivalents increased by 47.0% year-over-year, from $2.96B to $4.35B.
What is the long-term trend for Danaher's cash & equivalents?
Over 5 years (2020 to 2025), Danaher's cash & equivalents has grown at a -5.2% compound annual growth rate (CAGR), from $6.04B to $4.62B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.